CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
2.430
-0.250 (-9.33%)
At close: Oct 23, 2025, 4:00 PM EDT
2.310
-0.120 (-4.94%)
After-hours: Oct 23, 2025, 7:18 PM EDT

CytoMed Therapeutics Income Statement

Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Operating Revenue
0.230.07----
Upgrade
Other Revenue
0.50.430.510.360.110.06
Upgrade
0.730.50.510.360.110.06
Upgrade
Revenue Growth (YoY)
63.03%-0.86%39.52%219.67%91.43%-
Upgrade
Cost of Revenue
0.050.0300.0100
Upgrade
Gross Profit
0.680.470.50.360.110.05
Upgrade
Selling, General & Admin
0.740.650.490.210.170.14
Upgrade
Research & Development
2.11.911.591.521.091.04
Upgrade
Other Operating Expenses
0.830.922.160.370.490.11
Upgrade
Operating Expenses
4.23.64.352.211.851.37
Upgrade
Operating Income
-3.52-3.13-3.84-1.86-1.74-1.32
Upgrade
Interest Expense
-0.02-0.02-0.05-0.13-0.12-0.11
Upgrade
Interest & Investment Income
0.210.320.2900-
Upgrade
Earnings From Equity Investments
-0.010.01-0.03-0.03-0.21-
Upgrade
Currency Exchange Gain (Loss)
-0.240.16-0.17-0.03-0.01-0
Upgrade
Other Non Operating Income (Expenses)
-0.090.14-0.22---
Upgrade
EBT Excluding Unusual Items
-3.67-2.52-4.03-2.04-2.08-1.42
Upgrade
Gain (Loss) on Sale of Assets
-0--0--
Upgrade
Other Unusual Items
---0.1-1.090.02-0.51
Upgrade
Pretax Income
-3.68-2.52-4.13-3.13-2.05-1.94
Upgrade
Income Tax Expense
--00--
Upgrade
Earnings From Continuing Operations
-3.68-2.52-4.13-3.13-2.05-1.94
Upgrade
Minority Interest in Earnings
0.010.010000
Upgrade
Net Income
-3.67-2.52-4.13-3.13-2.05-1.94
Upgrade
Net Income to Common
-3.67-2.52-4.13-3.13-2.05-1.94
Upgrade
Shares Outstanding (Basic)
121211876
Upgrade
Shares Outstanding (Diluted)
121211876
Upgrade
Shares Change (YoY)
-8.56%34.30%14.14%17.59%6.22%
Upgrade
EPS (Basic)
-0.32-0.22-0.39-0.40-0.30-0.33
Upgrade
EPS (Diluted)
-0.32-0.22-0.39-0.40-0.30-0.33
Upgrade
Free Cash Flow
-3.99-4.11-3.59-1.87-2.3-1.09
Upgrade
Free Cash Flow Per Share
-0.35-0.36-0.34-0.24-0.33-0.19
Upgrade
Gross Margin
92.52%93.83%99.27%97.60%96.92%92.22%
Upgrade
Operating Margin
-482.59%-621.91%-756.86%-511.02%-1528.84%-2215.85%
Upgrade
Profit Margin
-503.11%-499.97%-813.98%-860.43%-1802.21%-3254.59%
Upgrade
Free Cash Flow Margin
-546.82%-816.52%-706.96%-514.47%-2016.27%-1839.93%
Upgrade
EBITDA
-3.18-2.8-3.46-1.47-1.41-1.03
Upgrade
D&A For EBITDA
0.340.330.380.390.330.29
Upgrade
EBIT
-3.52-3.13-3.84-1.86-1.74-1.32
Upgrade
Advertising Expenses
-0.020.03-00.01
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q